Current Mentored Research Career Development (KL2) Scholars

Tyler Barreto, MD, is an Assistant Professor in the Department of Family and Community Medicine and a Core Scholar of the Research to Advance Community Health (ReACH) Center. Dr. Barreto earned her undergraduate degree in Biochemistry from Grinnell College and completed medical school/residency training at Michigan State University. She has a wide variety interests including, health policy, health care delivery, innovative health models, health disparities, and point of care ultrasound. Dr. Barreto completed a Health Policy Fellowship at Georgetown University while serving as an Assistant Professor. Her most recent work has been focused on obstetric workforce shortages, identifying key variables in successful innovative care models, addressing behavioral health in primary care, and understanding the overuse of unnecessary care. The focus of Dr. Barreto's KL2 project is access to maternity care and maternal/neonatal outcomes. She aims to identify community, hospital, and individual level characteristics leading to disparities in access to maternity care to determine if access disparities lead to maternal and neonatal mortality.

Alex Bokov, PhD, in an Instructor/Researcher in the Clinical Informatics Research Division (CIRD) within the Department of Epidemiology and Biostatistics. He completed his doctoral degree in Physiology, then subsequently completed a Masters of Science in Statistics and a postdoctoral fellowship in biostatistics and data science. Dr. Bokov's KL2 research  focuses on using predictive analytics of electronic medical records and other large data sources to understand disparities in progression and possibly incidence of kidney cancer among Hispanic patients relative to non-Hispanic white patients, as well as identifying potential geographic hot-spots of kidney cancer. His analytical approaches can translate to a broad range of other problems in poulation health, health services research, and healthcare economics. He hopes to facilitate more effective use of informatics in translational science by disseminating his work as open source software that extends the functionality of i2b2 data warehouses and by extension, of SHRINE networks such as CTSA ACT. Dr. Bokov has four years of experience in every aspect of managing a research data warehouse and is proficient in RPython and various dialects of SQL.

Joseph B. Cantey, MD, is an Assistant Professor of Pediatrics within the Divisions of Neonatology & Allergy, Immunology, and Infectious Diseases.  Dr. Cantey completed his residency in pediatrics at John Hopkins before pursuing dual fellowship training at the University of Texas Southwestern Medical Center in pediatric infectious diseases and neonatology. While Dr. Cantey's clinical interests include all aspects of neonatal infections (congential and perinatal infections, nursery infection control and prevention), his primary research focus is neonatal antibiotic stewardship. He has designed and evaluated the utility and safety of single-center and system-wide neonatal antibiotic stewardship programs. He also studied the association between prolonged or unnecessary antibiotic exposure and adverse outcomes in young infants. Dr. Cantey has published over 40 peer-reviewed papers, 20 book chapters, editorials, and invited reviews. He serves as editor for Neonatal Infections as well as Nelson's Pediatric Antimicrobial Therapy. Dr. Cantey is excited to continue his research into the creation and implementation of innovative strategies to reduce unnecessary antibiotic use in neonates and young infants

Jennifer Knudtson, MD photo

Jennifer Knudtson, M.D. is an Assistant Professor in the Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility. Dr. Knudtson earned her B.S. in Biochemistry from the University of Texas at Austin and her Medical degree from the University of Texas Medical Branch at Galveston. She completed her residency and fellowship at the University of Texas Health Science Center at San Antonio. Dr. Knudtson’s research focuses on endometriosis and fertility preservation. She was awarded the Society for Reproductive Investigation’s New Investigator award in 2015. She has also received research grants from Vivere Health and the American Society for Reproductive Medicine. The goal of her KL2 project is to delineate the involvement of CD44 in the early endometriotic lesion.  Dr. Knudtson’s long-term career goal is to become an independently funded physician scientist whose research improves endometriosis patients’ quality of life. 

John Moring, PhD

John Moring, PhD, is an Assistant Research Professor and a licensed clinical psychologist within the Department of Psychiatry. He completed his doctoral degree at the University of Wyoming in 2013. His research focus includes psychosocial factors that facilitate health-related behaviors, as well as the genesis and maintenance of tinnitus. He completed his pre-doctoral internship at the University of California San Diego School of Medicine and San Diego VA Healthcare System. He later graduated from the STONG STAR Multidisciplinary PTSD Research Consortium Trauma Fellowship. During this fellowship he obtained extensive training in the treatment of post-traumatic stress disorder (PTSD) and the behavioral and emotional sequelae of traumatic brain injury related to blast exposure.  During his KL2 time, Dr. Moring will investigate the relationship between tinnitus-related distress and PTSD through cognitive-behavioral assessments and resting-state fMRI techniques. Additionally, he will examine changes in functional covariance among resting-state networks as a function of receiving empirically supported therapy for PTSD.

Josephine Taverna, MD is an Assistant Professor of Medicine in the Division of Hematology/Oncology. She received her medical degree from Mount Sinai School of Medicine and completed her Internal Medicine internship at Boston University Medical Center (BUMC). Dr. Taverna had the unique opportunity to enter into the Skin Oncology fellowship program at BUMC which led to the FDA approval of a skin cancer drug vorinostat. Subsequently, she has completed two Hematology-Oncology & Cancer Prevention fellowships, one at the University of Arizona and one at the University of Texas Health Science Center San Antonio. Dr. Taverna was among one of the first recipents of the Eli Lilly externships offered to NCATS KL2 scholars. She spent the first six months of her award developing a mathematical computer model to advance drug discovery at Eli Lilly. Her KL2 research is focusing on lung, head, and neck cancers studying the effects of an AXL inhibitor on tumor cells.







Top of Page